A Phase 2/3, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular
Research payments
$9,133,729
Through program year 2025, $9,133,729 in research payments was reported against A Phase 2/3, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular, across 1,531 payments, paid by Janssen Research & Development, LLC.
- Paid by
- Janssen Research & Development, LLC
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,809,251 | 413 |
| 2024 | Research | $5,471,719 | 889 |
| 2023 | Research | $1,852,759 | 229 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Arshad Khanani Reno, NV Named on 92 payments
- Brian DO Chevy Chase, MD Named on 81 payments
- Dante Pieramici Santa Barbara, CA Named on 49 payments
- David Eichenbaum St Petersburg, FL Named on 48 payments
- Thomas Aaberg Grand Rapids, MI Named on 47 payments
- Eric Jablon Charleston, SC Named on 47 payments
- Annal Meleth Marietta, GA Named on 40 payments
- Charles Wykoff Bellaire, TX Named on 37 payments
- Eduardo Uchiyama Ft Lauderdale, FL Named on 37 payments
- William Freeman San Diego, CA Named on 36 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.